Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lexaria Bioscience (LEXX) Other Non Operating Income (2022 - 2025)

Lexaria Bioscience's Other Non Operating Income history spans 4 years, with the latest figure at -$22080.0 for Q4 2025.

  • For Q4 2025, Other Non Operating Income fell 38.68% year-over-year to -$22080.0; the TTM value through Nov 2025 reached -$62901.0, down 146.2%, while the annual FY2025 figure was -$30697.0, 44.71% up from the prior year.
  • Other Non Operating Income for Q4 2025 was -$22080.0 at Lexaria Bioscience, down from -$15921.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $17299.0 in Q2 2023 and bottomed at -$134902.0 in Q3 2023.
  • The 4-year median for Other Non Operating Income is -$19000.5 (2024), against an average of -$27202.8.
  • The largest YoY upside for Other Non Operating Income was 112.23% in 2024 against a maximum downside of 339.28% in 2024.
  • A 4-year view of Other Non Operating Income shows it stood at -$73887.0 in 2022, then skyrocketed by 37.88% to -$45896.0 in 2023, then skyrocketed by 65.31% to -$15921.0 in 2024, then tumbled by 38.68% to -$22080.0 in 2025.
  • Per Business Quant, the three most recent readings for LEXX's Other Non Operating Income are -$22080.0 (Q4 2025), -$15921.0 (Q4 2024), and $16493.0 (Q3 2024).